Followers | 241 |
Posts | 12150 |
Boards Moderated | 3 |
Alias Born | 04/05/2009 |
Monday, April 27, 2015 3:14:49 PM
LITTLE ELM, Texas--(BUSINESS WIRE)--Retractable Technologies, Inc. (NYSE MKT: RVP) (“RTI”) announced that on April 23, 2015, the United States District Court for the Eastern District of Texas, Marshall Division, entered an Amended Final Judgment in RTI’s suit against Becton, Dickinson and Company (“BD”) for antitrust and other claims.
The Amended Final Judgment states:
1. BD attempted to monopolize the safety syringe market.
2. BD committed false advertising under the Lanham Act.
3. RTI recovers from BD $340,524,042.00.
4. RTI recovers from BD its attorneys’ fees in the amount of $11,722,823.20.
5. RTI is further awarded post-judgment interest and costs.
6. The Court GRANTS injunctive relief consistent with its prior orders.
On April 24, 2015, BD filed a Notice of Appeal announcing its appeal of the Amended Final Judgment and various other post-trial and post judgment orders to the United States Court of Appeals for the Fifth Circuit.
RTI manufactures and markets VanishPoint® and Patient Safe® safety medical products. The VanishPoint® syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe® syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. RTI’s products are distributed by various specialty and general line distributors.
For more information on RTI, visit our website at www.vanishpoint.com.
http://www.businesswire.com/news/home/20150427006168/en/Retractable-Technologies-Announces-Amended-Final-Judgment-Notice#.VT6FeIktGUk
"Someone said it takes 30 years to be an instant success" - Gabriel Barbier-Mueller, CEO of Harwood International
Recent BDX News
- BD Expands Capacity for Advanced Prefillable Syringes and Enhances Injection Experience for the Next Generation of Biologics • PR Newswire (US) • 09/18/2024 10:50:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/16/2024 03:52:44 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/09/2024 07:46:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 06:57:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/04/2024 06:56:53 PM
- BD Completes Acquisition of Critical Care from Edwards Lifesciences • PR Newswire (US) • 09/03/2024 08:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:16:36 PM
- BD Celebrates 75 years of U.S. Manufacturing Excellence in Nebraska • PR Newswire (US) • 08/22/2024 05:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 03:23:25 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 08/21/2024 03:21:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/15/2024 05:47:05 PM
- BD Names Michael Feld as President of Life Sciences Segment • PR Newswire (US) • 08/12/2024 10:50:00 AM
- BD to Present at Wells Fargo 2024 Healthcare Conference • PR Newswire (US) • 08/08/2024 08:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 07:53:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/02/2024 07:51:19 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/01/2024 08:33:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/01/2024 10:32:40 AM
- BD Reports Third Quarter Fiscal 2024 Financial Results • PR Newswire (US) • 08/01/2024 10:30:00 AM
- BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases • PR Newswire (US) • 07/25/2024 10:45:00 AM
- BD Board Declares Dividend • PR Newswire (US) • 07/23/2024 08:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/12/2024 10:01:14 AM
- Costco Hikes Membership Fees; ON Semiconductor Stock Drops 3%; WD-40 Soars 13% on Strong Q3 Earnings • IH Market News • 07/11/2024 10:17:26 AM
- BD Statement on Supplier Issue Impacting BD BACTEC™ Blood Culture Vials • PR Newswire (US) • 07/10/2024 04:12:00 PM
- BD Surpasses Scope 1 and 2 Reduction Milestones for FY 2023 • PR Newswire (US) • 07/10/2024 10:50:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM